{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,31]],"date-time":"2025-10-31T21:40:24Z","timestamp":1761946824080,"version":"build-2065373602"},"reference-count":54,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2019,1,1]],"date-time":"2019-01-01T00:00:00Z","timestamp":1546300800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,1,1]],"date-time":"2019-01-01T00:00:00Z","timestamp":1546300800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"name":"Lui Che Woo Institute of Innovative Medicine BRAIN Initiative","award":["8303404"],"award-info":[{"award-number":["8303404"]}]},{"DOI":"10.13039\/501100004853","name":"Chinese University of Hong Kong","doi-asserted-by":"publisher","award":["7105306"],"award-info":[{"award-number":["7105306"]}],"id":[{"id":"10.13039\/501100004853","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Pharmaceutical Sciences"],"published-print":{"date-parts":[[2019,1]]},"DOI":"10.1016\/j.ejps.2018.10.025","type":"journal-article","created":{"date-parts":[[2018,11,1]],"date-time":"2018-11-01T16:01:43Z","timestamp":1541088103000},"page":"240-251","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":5,"special_numbering":"C","title":["Efficient brain uptake and distribution of an expanded CAG RNA inhibitor DB213 via intranasal administration"],"prefix":"10.1016","volume":"127","author":[{"given":"Qianwen","family":"Wang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shaohong","family":"Peng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yue","family":"Hu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chun-Ho","family":"Wong","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kin Ming","family":"Kwan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"H.Y. Edwin","family":"Chan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6976-6157","authenticated-orcid":false,"given":"Zhong","family":"Zuo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejps.2018.10.025_bb0005","doi-asserted-by":"crossref","first-page":"12453","DOI":"10.1073\/pnas.91.26.12453","article-title":"Universal biological scaling and mortality","volume":"91","author":"Azbel Mya","year":"1994","journal-title":"Proc. Natl. Acad. Sci."},{"key":"10.1016\/j.ejps.2018.10.025_bb0010","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pgen.1002481","article-title":"A pathogenicmechanism in Huntington's disease involves small CAG-repeated RNAs with neurotoxic activity","volume":"8","author":"Ba\u00f1ez-Coronel","year":"2012","journal-title":"PLoS Genet."},{"year":"2017","series-title":"Small Molecule Inhibitors Targeting Cag-repeat RNA Toxicity in Polyglutamine Diseases","author":"Chan","key":"10.1016\/j.ejps.2018.10.025_bb0015"},{"key":"10.1016\/j.ejps.2018.10.025_bb0020","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1002\/jps.2600790402","article-title":"Pharmacokinetic correlation between in vitro hepatic microsomal enzyme kinetics and in vivo metabolism of imipramine and desipramine in rats","volume":"79","author":"Chiba","year":"1990","journal-title":"J. Pharm. Sci."},{"key":"10.1016\/j.ejps.2018.10.025_bb0025","doi-asserted-by":"crossref","first-page":"897","DOI":"10.3233\/JAD-141791","article-title":"Long-acting intranasal insulin detemir improves cognition for adults with mild cognitive impairment or early-stage Alzheimer's disease dementia","volume":"44","author":"Claxton","year":"2015","journal-title":"J. Alzheimers Dis."},{"key":"10.1016\/j.ejps.2018.10.025_bb0030","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1016\/j.antiviral.2011.09.012","article-title":"Brain distribution of ribavirin after intranasal administration","volume":"92","author":"Colombo","year":"2011","journal-title":"Antivir. Res."},{"key":"10.1016\/j.ejps.2018.10.025_bb0035","doi-asserted-by":"crossref","first-page":"1654","DOI":"10.1002\/jps.21924","article-title":"Intranasal delivery to the central nervous system: mechanisms and experimental considerations","volume":"99","author":"Dhuria","year":"2010","journal-title":"J. Pharm. Sci."},{"key":"10.1016\/j.ejps.2018.10.025_bb0040","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/j.ab.2008.03.048","article-title":"Quantitative gene expression analysis in a brain slice model: influence of temperature and incubation media","volume":"378","author":"Dos-Anjos","year":"2008","journal-title":"Anal. Biochem."},{"key":"10.1016\/j.ejps.2018.10.025_bb0045","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1038\/25977","article-title":"Allometric scaling of plant energetics and population density","volume":"395","author":"Enquist","year":"1998","journal-title":"Nature"},{"key":"10.1016\/j.ejps.2018.10.025_bb0050","doi-asserted-by":"crossref","first-page":"441","DOI":"10.3727\/096368914X678454","article-title":"Polyglutamine (PolyQ) diseases: genetics to treatments","volume":"23","author":"Fan","year":"2014","journal-title":"Cell Transplant."},{"key":"10.1016\/j.ejps.2018.10.025_bb0055","doi-asserted-by":"crossref","first-page":"1555","DOI":"10.1038\/sj.bjp.0704390","article-title":"Evidence of P-glycoprotein mediated apical to basolateral transport of flunisolide in human broncho-tracheal epithelial cells (Calu-3)","volume":"134","author":"Florea","year":"2001","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.ejps.2018.10.025_bb0060","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1016\/S0168-3659(02)00356-5","article-title":"Drug transport and metabolism characteristics of the human airway epithelial cell line Calu-3","volume":"87","author":"Florea","year":"2003","journal-title":"J. Control. Release"},{"key":"10.1016\/j.ejps.2018.10.025_bb0065","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0378-5173(00)00452-X","article-title":"Characterization of the Calu-3 cell line as a tool to screen pulmonary drug delivery","volume":"208","author":"Foster","year":"2000","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.ejps.2018.10.025_bb0070","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0001595","article-title":"Genetic and chemical modifiers of a CUG toxicity model in drosophila","volume":"3","author":"Garcia-Lopez","year":"2008","journal-title":"PLoS One"},{"key":"10.1016\/j.ejps.2018.10.025_bb0075","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1016\/S0378-5173(01)00836-5","article-title":"Modulation of P-glycoprotein activity in Calu-3 cells using steroids and beta-ligands","volume":"228","author":"Hamilton","year":"2001","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.ejps.2018.10.025_bb0080","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1124\/dmd.30.1.13","article-title":"The anti-influenza drug oseltamivir exhibits low potential to induce pharmacokinetic drug interactions via renal secretion-correlation of in vivo and in vitro studies","volume":"30","author":"Hill","year":"2002","journal-title":"Drug Metab. Dispos."},{"key":"10.1016\/j.ejps.2018.10.025_bb0085","doi-asserted-by":"crossref","first-page":"1469","DOI":"10.1016\/0006-2952(94)90520-7","article-title":"Utility of in vitro drug metabolism data in predicting in vivo metabolic clearance","volume":"47","author":"Houston","year":"1994","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.ejps.2018.10.025_bb0090","doi-asserted-by":"crossref","first-page":"4819","DOI":"10.1128\/JVI.72.6.4819-4824.1998","article-title":"Importance of ribosomal frameshifting for human immunodeficiency virus type 1 particle assembly and replication","volume":"72","author":"Hung","year":"1998","journal-title":"J. Virol."},{"key":"10.1016\/j.ejps.2018.10.025_bb0095","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1016\/S0896-6273(03)00533-6","article-title":"RNA-mediated neurodegeneration caused by the fragile X premutation rCGG repeats in Drosophila","volume":"39","author":"Jin","year":"2003","journal-title":"Neuron"},{"key":"10.1016\/j.ejps.2018.10.025_bb0100","doi-asserted-by":"crossref","first-page":"1199","DOI":"10.1211\/jpp.59.9.0003","article-title":"Nose-to-brain delivery of tacrine","volume":"59","author":"Jogani","year":"2007","journal-title":"J. Pharm. Pharmacol."},{"key":"10.1016\/j.ejps.2018.10.025_bb0105","doi-asserted-by":"crossref","first-page":"897","DOI":"10.1016\/j.neuron.2010.09.012","article-title":"PolyQ disease: too many Qs, too much function?","volume":"67","author":"Kratter","year":"2010","journal-title":"Neuron"},{"key":"10.1016\/j.ejps.2018.10.025_bb0110","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1111\/j.1471-4159.2009.06124.x","article-title":"The role of ubiquitin linkages on \u03b1-synuclein induced-toxicity in a Drosophila model of Parkinson's disease","volume":"110","author":"Lee","year":"2009","journal-title":"J. Neurochem."},{"key":"10.1016\/j.ejps.2018.10.025_bb0115","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1208\/s12248-011-9310-9","article-title":"Comparison of intestinal absorption and disposition of structurally similar bioactive flavones in radix scutellariae","volume":"14","author":"Li","year":"2012","journal-title":"AAPS J."},{"key":"10.1016\/j.ejps.2018.10.025_bb0120","doi-asserted-by":"crossref","first-page":"614","DOI":"10.1016\/j.addr.2011.11.002","article-title":"Intranasal delivery of biologics to the central nervous system","volume":"64","author":"Lochhead","year":"2012","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.ejps.2018.10.025_bb0125","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1186\/2045-8118-10-6","article-title":"The brain slice method for studying drug distribution in the CNS","volume":"10","author":"Loryan","year":"2013","journal-title":"Fluid. Barriers CNS"},{"key":"10.1016\/j.ejps.2018.10.025_bb0130","doi-asserted-by":"crossref","first-page":"857","DOI":"10.1021\/cb200082d","article-title":"Structure of the HIV-1 frameshift site RNA bound to a small molecule inhibitor of viral replication","volume":"6","author":"Marcheschi","year":"2011","journal-title":"ACS Chem. Biol."},{"key":"10.1016\/j.ejps.2018.10.025_bb0135","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1126\/science.310.5745.43","article-title":"Neurodegeneration: Huntington's research points to possible new therapies","volume":"310","author":"Marx","year":"2005","journal-title":"Science"},{"key":"10.1016\/j.ejps.2018.10.025_bb0140","doi-asserted-by":"crossref","first-page":"1201","DOI":"10.1126\/science.179.4079.1201","article-title":"Size and shape in biology","volume":"179","author":"McMahon","year":"1973","journal-title":"Science"},{"key":"10.1016\/j.ejps.2018.10.025_bb0145","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1089\/scd.2017.0148","article-title":"Intranasal stem cell treatment as a novel therapy for subarachnoid hemorrhage","volume":"27","author":"Nijboer","year":"2018","journal-title":"Stem Cells Dev."},{"key":"10.1016\/j.ejps.2018.10.025_bb0150","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1016\/j.jneumeth.2012.06.010","article-title":"Approach to reduce the non-specific binding in microdialysis","volume":"209","author":"Nirogi","year":"2012","journal-title":"J. Neurosci. Methods"},{"key":"10.1016\/j.ejps.2018.10.025_bb0155","doi-asserted-by":"crossref","first-page":"452","DOI":"10.2133\/dmpk.20.452","article-title":"Tissue-specific mRNA expression profiles of human ATP-binding cassette and solute carrier transporter superfamilies","volume":"20","author":"Nishimura","year":"2005","journal-title":"Drug Metab. Pharmacokinet."},{"key":"10.1016\/j.ejps.2018.10.025_bb0160","doi-asserted-by":"crossref","DOI":"10.1371\/annotation\/57e0a947-8600-4658-b04c-cf7a45c8bd8d","article-title":"A novel retro-inverso peptide inhibitor reduces amyloid deposition, oxidation and inflammation and stimulates neurogenesis in the APPswe\/PS1\u0394E9 mouse model of Alzheimer's disease","volume":"8","author":"Parthsarathy","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.ejps.2018.10.025_bb0165","doi-asserted-by":"crossref","first-page":"1849","DOI":"10.1074\/mcp.M500090-MCP200","article-title":"Proteomic analysis of protein expression and oxidative modification in R6\/2 transgenic mice","volume":"4","author":"Perluigi","year":"2005","journal-title":"Mol. Cell. Proteomics"},{"key":"10.1016\/j.ejps.2018.10.025_bb0170","doi-asserted-by":"crossref","first-page":"442","DOI":"10.1016\/j.ijpharm.2014.10.058","article-title":"Synthesis, biological activity, and biopharmaceutical characterization of tacrine dimers as acetylcholinesterase inhibitors","volume":"477","author":"Qian","year":"2014","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.ejps.2018.10.025_bb0175","doi-asserted-by":"crossref","first-page":"1491","DOI":"10.1517\/17425255.2014.956080","article-title":"Improved brain uptake of peptide-based CNS drugs via alternative routes of administrations of its nanocarrier delivery systems: a promising strategy for CNS targeting delivery of peptides","volume":"10","author":"Qian","year":"2014","journal-title":"Expert Opin. Drug Metab. Toxicol."},{"key":"10.1016\/j.ejps.2018.10.025_bb0180","doi-asserted-by":"crossref","first-page":"428","DOI":"10.1016\/j.lfs.2018.06.032","article-title":"Intranasal delivery of a novel acetylcholinesterase inhibitor HLS-3 for treatment of Alzheimer's disease","volume":"207","author":"Qian","year":"2018","journal-title":"Life Sci."},{"key":"10.1016\/j.ejps.2018.10.025_bb0185","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1016\/0003-2697(90)90461-H","article-title":"Preparation of brain microsomes with cytochrome P450 activity using calcium aggregation method","volume":"187","author":"Ravindranath","year":"1990","journal-title":"Anal. Biochem."},{"key":"10.1016\/j.ejps.2018.10.025_bb0190","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1016\/0003-2697(86)90091-6","article-title":"Adaptation of the bicinchoninic acid protein assay for use with microtiter plates and sucrose gradient fractions","volume":"153","author":"Redinbaugh","year":"1986","journal-title":"Anal. Biochem."},{"key":"10.1016\/j.ejps.2018.10.025_bb0195","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1016\/0378-4347(95)00274-X","article-title":"High-performance liquid chromatographic method for the analysis of imipramine metabolism in vitro by liver and brain microsomes","volume":"673","author":"Sequeira","year":"1995","journal-title":"J. Chromatogr. B Biomed. Sci. Appl."},{"key":"10.1016\/j.ejps.2018.10.025_bb0200","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1016\/0006-8993(96)00759-7","article-title":"In vitro metabolism of imipramine by brain microsomes: effects of inhibitors and exogenous cytochrome P450 reductase","volume":"738","author":"Sequeira","year":"1996","journal-title":"Brain Res."},{"key":"10.1016\/j.ejps.2018.10.025_bb0205","doi-asserted-by":"crossref","first-page":"1313","DOI":"10.1021\/jm000407e","article-title":"Property-based design: optimization of drug absorption and pharmacokinetics","volume":"44","author":"van de Waterbeemd","year":"2001","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ejps.2018.10.025_bb0210","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1023\/A:1008192010023","article-title":"Lipophilicity in PK design: methyl, ethyl, futile","volume":"15","author":"van de Waterbeemd","year":"2001","journal-title":"J. Comput. Aided Mol. Des."},{"key":"10.1016\/j.ejps.2018.10.025_bb0215","doi-asserted-by":"crossref","first-page":"961","DOI":"10.1080\/17425255.2018.1513493","article-title":"Impact of transporters and enzymes from blood\u2013cerebrospinal fluid barrier and brain parenchyma on CNS drug uptake","volume":"14","author":"Wang","year":"2018","journal-title":"Expert Opin. Drug Metab. Toxicol."},{"key":"10.1016\/j.ejps.2018.10.025_bb0220","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/j.ijpharm.2011.08.019","article-title":"An approach for rapid development of nasal delivery of analgesics-identification of relevant features, in vitro screening and in vivo verification","volume":"420","author":"Wang","year":"2011","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.ejps.2018.10.025_bb0225","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/j.jpba.2016.03.025","article-title":"Pharmacokinetics and brain uptake of HIV-1 replication inhibitor DB213 in Sprague-Dawley rats","volume":"125","author":"Wang","year":"2016","journal-title":"J. Pharm. Biomed. Anal."},{"key":"10.1016\/j.ejps.2018.10.025_bb0230","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1016\/j.ijpharm.2018.01.032","article-title":"Statistical Design of Experiment (DoE) based development and optimization of DB213 in situ thermosensitive gel for intranasal delivery","volume":"539","author":"Wang","year":"2018","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.ejps.2018.10.025_bb0235","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1208\/s12248-017-0179-0","article-title":"Demonstration of direct nose-to-brain transport of unbound HIV-1 replication inhibitor DB213 via intranasal administration by pharmacokinetic modeling","volume":"20","author":"Wang","year":"2018","journal-title":"AAPS J."},{"key":"10.1016\/j.ejps.2018.10.025_bb0240","doi-asserted-by":"crossref","first-page":"4586","DOI":"10.1002\/jps.21317","article-title":"Validation of a rapid equilibrium dialysis approach for the measurement of plasma protein binding","volume":"97","author":"Waters","year":"2008","journal-title":"J. Pharm. Sci."},{"key":"10.1016\/j.ejps.2018.10.025_bb0245","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1083\/jcb.71.1.303","article-title":"Cytochalasin B inhibits actin-related gelation of Hela cell extracts","volume":"71","author":"Weihing","year":"1976","journal-title":"J. Cell Biol."},{"key":"10.1016\/j.ejps.2018.10.025_bb0250","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1208\/s12248-012-9366-1","article-title":"Physiologically based pharmacokinetic modeling to investigate regional brain distribution kinetics in rats","volume":"14","author":"Westerhout","year":"2012","journal-title":"AAPS J."},{"key":"10.1016\/j.ejps.2018.10.025_bb0255","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1002\/cpt1975184377","article-title":"Commentary: a physiological approach to hepatic drug clearance","volume":"18","author":"Wilkinson","year":"1975","journal-title":"Clin. Pharmacol. Ther."},{"key":"10.1016\/j.ejps.2018.10.025_bb0260","doi-asserted-by":"crossref","first-page":"2368","DOI":"10.1007\/s11095-013-1080-x","article-title":"Brain disposition and catalepsy after intranasal delivery of loxapine: role of metabolism in PK\/PD of intranasal CNS drugs","volume":"30","author":"Wong","year":"2013","journal-title":"Pharm. Res."},{"key":"10.1016\/j.ejps.2018.10.025_bb0265","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1111\/j.1745-7254.2007.00486.x","article-title":"Drug brain distribution following intranasal administration of Huperzine A in situ gel in rats","volume":"28","author":"Zhao","year":"2007","journal-title":"Acta Pharmacol. Sin."},{"key":"10.1016\/j.ejps.2018.10.025_bb0270","article-title":"Cultured human airway epithelial cells (calu-3): a model of human respiratory function, structure, and inflammatory responses","volume":"2010","author":"Zhu","year":"2010","journal-title":"Crit. Care Res. Prac."}],"container-title":["European Journal of Pharmaceutical Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0928098718304780?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0928098718304780?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,15]],"date-time":"2025-10-15T11:48:49Z","timestamp":1760528929000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0928098718304780"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,1]]},"references-count":54,"alternative-id":["S0928098718304780"],"URL":"https:\/\/doi.org\/10.1016\/j.ejps.2018.10.025","relation":{},"ISSN":["0928-0987"],"issn-type":[{"type":"print","value":"0928-0987"}],"subject":[],"published":{"date-parts":[[2019,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Efficient brain uptake and distribution of an expanded CAG RNA inhibitor DB213 via intranasal administration","name":"articletitle","label":"Article Title"},{"value":"European Journal of Pharmaceutical Sciences","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejps.2018.10.025","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}